Recombinant protein vaccines can be divided into recombinant spike-protein-based vaccines, recombinant RBD-based vaccines, and virus-like particle (VLP)-based vaccines.
Part 1: SARS-CoV-2 Vaccines Development: An Overview
Part 2: Inactivated Vaccines
Part 4: Viral Vectors
Part 5: Genetic Vaccines
Part 6: Monoclonal Antibodies
This is a snapshot of emerging vaccines during a rapidly evolving pandemic. Any and all information currently available related to COVID-19 is subject to change as more details become available.
This article originally appeared on Univadis, part of the Medscape Professional Network.
